Ectin Research AB (XSAT:ECTIN B) Days Payable : 0.00 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Days Payable?

Ectin Research AB's average Accounts Payable for the three months ended in Mar. 2024 was kr0.85 Mil. Ectin Research AB's Cost of Goods Sold for the three months ended in Mar. 2024 was kr0.00 Mil.

The historical rank and industry rank for Ectin Research AB's Days Payable or its related term are showing as below:

XSAT:ECTIN B's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 127.37
* Ranked among companies with meaningful Days Payable only.

Ectin Research AB's Days Payable stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00). stayed the same

Ectin Research AB Days Payable Historical Data

The historical data trend for Ectin Research AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Days Payable Chart

Ectin Research AB Annual Data

Trend

Aug19

Aug20

Dec22

Dec23

Days Payable

Ectin Research AB Quarterly Data
	Aug19	Aug20	Mar21	Sep21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial								-	-	-	-	-

Competitive Comparison of Ectin Research AB's Days Payable

For the Biotechnology subindustry, Ectin Research AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ectin Research AB's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ectin Research AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Ectin Research AB's Days Payable falls into.

Ectin Research AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Ectin Research AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.729	+	0.719)	/	2 )	/	0	*	365
=	0.724					/	0	*	365
=	N/A

Ectin Research AB's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (0.719	+	0.988)	/	2 )	/	0	*	365 / 4
=	0.8535					/	0	*	365 / 4
=	N/A

Ectin Research AB Days Payable Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Ectin Research AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Pepparedsleden 1, Molndal, SWE, 431 83

Website

https://www.ectinresearch.com

Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB Headlines

No Headlines